Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Muscle-Invasive Bladder Cancer (NMIBC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07735793
What this trial is testing

Radical Cystectomy in Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) and Muscle Invasive Bladder Cancer (MIBC) in Korea

Who this might be right for
Urinary Bladder Neoplasms
Janssen Korea, Ltd., Korea 1
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06255964
What this trial is testing

IAP0971 in Combination With Bacillus Calmette Guerin in High Risk Non-muscular Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
SUNHO（China）BioPharmaceutical CO., Ltd. 236
Not applicableUnknownNCT05671900
What this trial is testing

Gemcitabine and Docetaxel Therapy in High-risk BCG-naive Patients With Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle-invasive Bladder Cancer
Clinical Hospital Centre Zagreb 70
Not applicableUnknownNCT03148158
What this trial is testing

Assessment Of Bladder Tumors Stage And Grade By Outpatient Flexible Cystoscopy Performed By Urology Resident

Who this might be right for
Bladder CancerFlexible CystoscopyNon-muscle Invasive Bladder Cancer (NMIBC)+1 more
Mansoura University 300
Not applicableLooking for participantsNCT02660645
What this trial is testing

Blue Light Cystoscopy With Cysview® Registry

Who this might be right for
Bladder Cancer
Photocure 4,400
Early research (Phase 1)WithdrawnNCT04109092
What this trial is testing

Stimulator of Interferon Genes (STING) Agonist E7766 in Non-muscle Invasive Bladder Cancer (NMIBC) Including Participants Unresponsive to Bacillus Calmette-Guerin (BCG) Therapy, INPUT-102

Who this might be right for
Urinary Bladder Neoplasms
Eisai Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT05410730
What this trial is testing

SHR-1501 Alone or in Combination With BCG or SHR-1316 in Subjects With NMIBC

Who this might be right for
High-risk NMIBC
Shanghai Hengrui Pharmaceutical Co., Ltd. 150
Not applicableUnknownNCT05176145
What this trial is testing

Demonstration of the Medical Interest of the VisioCyt® Artificial Intelligence Test

Who this might be right for
Non-muscle Invasive Bladder Cancer (NMIBC)
Vitadx 400
Early research (Phase 1)Active Not RecruitingNCT06181266
What this trial is testing

A Phase 1/1b Study of ZH9 Treatment in Patients With Non-Muscle Invasive Bladder Cancer

Who this might be right for
NMIBCHigh Risk NMIBCNon Muscle Invasive Bladder Cancer
Prokarium Ltd 22
Testing effectiveness (Phase 2)Ended earlyNCT03519256
What this trial is testing

Nivolumab or Nivolumab Plus Experimental Medication BMS-986205 With or Without Bacillus Calumette-Guerin (BCG) in BCG Unresponsive Bladder Cancer That Has Not Invaded Into the Muscle Wall of the Bladder

Who this might be right for
Urinary Bladder Neoplasms
Bristol-Myers Squibb 142
Not applicableStudy completedNCT07798479
What this trial is testing

Age and Bladder Cancer Outcomes After BCG Treatment: A Multicenter Study

Who this might be right for
Bladder CancerNMIBC
Insel Gruppe AG, University Hospital Bern 64
Not applicableAvailableNCT06810141
What this trial is testing

ResQ132EX-NMIBC: Expanded Access Use of Recombinant Bacillus Calmette-Guérin in Nonmuscle Invasive Bladder Cancer

Who this might be right for
NMIBC
ImmunityBio, Inc.
Large-scale testing (Phase 3)Ended earlyNCT01410565
What this trial is testing

Efficacy and Safety of Multi-Instillations of Apaziquone in Patients With Non-Muscle Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
Spectrum Pharmaceuticals, Inc 66
Testing effectiveness (Phase 2)UnknownNCT05975151
What this trial is testing

Efficacy and Safety of Pseudomonas Aeruginosa for Intermediate and High-risk Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
Qilu Hospital of Shandong University 63
Not applicableStudy completedNCT03664258
What this trial is testing

A Multi-National Study In Bladder Cancer Patients to Detect Recurrences After TURB (Trans-urethral Resection of the Bladder) Earlier With the Xpert Bladder Cancer Monitor Assay (ANTICIPATE X)

Who this might be right for
Non-muscle-invasive Bladder Cancer
Cepheid 852
Large-scale testing (Phase 3)Ended earlyNCT04149574
What this trial is testing

A Study Comparing the Efficacy and Safety of Nivolumab in Combination With Bacillus Calmette-Guerin (BCG) Versus BCG Alone in Participants With High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC)

Who this might be right for
Urinary Bladder Neoplasms
Bristol-Myers Squibb 13
Early research (Phase 1)Not Yet RecruitingNCT07260162
What this trial is testing

Evaluation of ATO-101™ in Patients With Non-Muscle-Invasive Bladder Cancer (PERSEVERANCE EU)

Who this might be right for
Bladder Cancer
Institut Cancerologie de l'Ouest 24
Early research (Phase 1)Ended earlyNCT06448364
What this trial is testing

A Study in Advanced/Metastatic Solid Tumors With the Study Medicine (PF-07329640) When Given Alone or In Combination

Who this might be right for
Advanced or Metastatic Solid TumorsNon-Small Cell Lung CancerColorectal Cancer+2 more
Pfizer 4
Testing effectiveness (Phase 2)Study completedNCT04172675
What this trial is testing

Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)

Who this might be right for
Urinary Bladder Neoplasms
Janssen Research & Development, LLC 107
Not applicableLooking for participantsNCT06287541
What this trial is testing

The Necessity of a Second Transurethral Resection in High-risk Non-muscle-invasive Bladder Cancer Patients With Negative Urine Biomarker After Initial Transurethral Resection

Who this might be right for
Non Muscle Invasive Bladder Cancer
The First Affiliated Hospital with Nanjing Medical University 428
Next Page